4 minutes ( <0.001). ED boarding impacts length of stay for all patients admitted through the ED and not just those admitted patients who are boarded. This study provides an estimate for the increased ED length of stay experienced by all patients admitted to the hospital as a function of patient boarding. ED boarding impacts length of stay for all patients admitted through the ED and not just those admitted patients who are boarded. This study provides an estimate for the increased ED length of stay experienced by all patients admitted to the hospital as a function of patient boarding. The 2019-20 coronavirus pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). This study was undertaken to identify and compare findings of chest radiography and computed tomography among patients with SARS-CoV-2 infection. This retrospective study was undertaken at a tertiary care center. Eligible subjects included consecutive patients age 18 and over with documented SARS-CoV-2 infection between March and July 2020. The primary outcome measures were results of chest radiography and computed tomography among patients with documented SARS-CoV-2 infection. Among 724 subjects, most were admitted to a medical floor (46.4%; N=324) or admitted to an ICU (10.9%; N=76). A substantial number of subjects were intubated during the emergency department visit or inpatient hospitalization (15.3%; N=109). The majority of patients received a chest radiograph (80%; N=579). The most common findings were normal, bilateral infiltrates, grouoV-2 infection include infiltrates or ground-glass opacities. There was considerable disagreement between chest radiography and computed tomography. Computed tomography was more accurate in defining the extent of involved lung parenchyma. The presence of bilateral infiltrates was associated with morbidity and mortality. Presence of ethanol (EtOH) may alter the relationship between blood lactate concentrations and mortality. This study compares lactate-associated mortality risk in the presence and absence of EtOH. We performed a retrospective cohort study including all patients, age>17 years, presenting from January 2012-December 2018, to an urban, academic emergency department, with a clinically measured lactate. Data were electronically abstracted from the medical record. The primary outcome was 28-day in-hospital mortality. Patients were grouped by EtOH test results as follows 1) present (any EtOH detected), 2) absent (EtOH concentration measured and not detected), or 3) not ordered. Marginal analysis was used to calculated probability of mortality for fixed values of lactate and model covariates. Of 40,956 adult emergency department patients with measured lactate, we excluded 768 (1.89%) for lactate>10.0mmol/L, leaving 40,240 for analysis 4,066 (10.1%) EtOH present, 10,819 (26.9%) EtOH absent, 25,355 (63%) EtOH not ordered. Of these, 1790 (4.4%) had 28-day in-hospital mortality. Marginal probability of mortality calculated for specific lactate values found less risk for EtOH Present patients versus EtOH absent patients at lactate 0.0mmol/L (0.8% [95%CI 0.5-1.2%] vs 3.2% [2.8-3.6%]), 2.0mmol/L (1.5% [1.1-1.9%] vs 4.0% [3.7-4.3%]), 4.0mmol/L (2.6% [2.2-3.1%] vs 5.0% [4.6-5.4%]), until 6.0mmol/L (4.5% [3.7-5.4%] vs 6.2% [5.4-7.0%]). EtOH presence significantly alters lactate-associated mortality risk when lactate<6.0mmol/L. Emergency department clinicians should interpret these lactate values with caution and consider other data for risk stratification when EtOH is present. EtOH presence significantly alters lactate-associated mortality risk when lactate less then 6.0 mmol/L. Emergency department clinicians should interpret these lactate values with caution and consider other data for risk stratification when EtOH is present. In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. We performed a retrospective study of pediatric patients(≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile-de-France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also exandation for this practice can be made. In a 3-year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made. Currently, there are no guidelines to help triage nurses identify high-risk emergency department chest pain patients. Patient self-reporting of Emergency Department Assessment of Chest Pain Score (EDACS) could facilitate more reliable triage compared to nursing gestalt, but this novel concept is untested. This study hypothesizes that because EDACS requires minimal clinical gestalt to derive, self-reported EDACS (S-EDACS) at triage is likely to correlate well with traditional physician-reported EDACS (P-EDACS) and have potential application as a triage tool. This single-center pilot prospective cohort study analyzed 60 patients who completed a self-reported questionnaire upon triage to determine their S-EDACS. This was matched against P-EDACS, derived from an identical questionnaire completed by the blinded treating physician. https://www.selleckchem.com/products/gdc-0068.html Secondary endpoint of major adverse cardiovascular events (MACE) within 30 days (all-cause mortality, myocardial infarction, coronary revascularization) was assessed by 2 blinded emergency physicians who independently reviewed the electronic medical records.